Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Neuroendocrine aspects of pediatric aggression: Can hormone measures be clinically useful?

Authors Drew H Barzman, Avni Patel, Loretta Sonnier, et al

Published Date October 2010 Volume 2010:6(1) Pages 691—697

DOI http://dx.doi.org/10.2147/NDT.S5832

Published 11 October 2010

Drew H Barzman1, Avni Patel2, Loretta Sonnier1, Jeffrey R Strawn3
1Division of Child and Adolescent Psychiatry, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA; 2Miami University, Oxford, OH, USA; 3Department of Psychiatry, University of Cincinnati, College of Medicine, Cincinnati, OH, USA

Abstract: Pediatric aggression is common in human societies, mainly presenting as impulsive aggression or predatory aggression. Numerous psychiatric disorders can contain aggression as a symptom, leading to difficulties in diagnosis and treatment. This review focuses on the biological systems that affect pediatric aggression. We review the hypothalamic–pituitary–adrenal (HPA) axis, the hypothalamic–pituitary–gonadal (HPG) axis, and the mechanisms by which these axes influence the body and mind of aggressive children and adolescents. Although this review focuses on the HPA and HPG axes, it is important to note that other biological systems have relationships with these two axes. Based on the results of the studies reviewed, elevated cortisol concentrations were associated with impulsive aggression, whereas, low levels of cortisol were associated with callous-unemotional traits similar to predatory aggression. Higher levels of dehydroepiandrosterone were correlated with higher levels of aggression as were higher levels of testosterone. However, there have been discrepancies in the results between various studies, indicating the need for more research on hormonal levels and pediatric aggression. In the future, hormonal levels may be useful in determining what treatments will work best for certain pediatric patients.

Keywords: youth, cortisol, adrenocorticotropin-releasing hormone, corticotropin-releasing hormone, HPA axis, HPG axis

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer

Chauhan A, Zubair S, Tufail S, Sherwani A, Sajid M, Raman SC, Azam A, Owais M

International Journal of Nanomedicine 2011, 6:2305-2319

Published Date: 12 October 2011

Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis

Julie A Murphy, Jacklyn A Harris, Andrew J Crannage

Neuropsychiatric Disease and Treatment 2010, 6:619-625

Published Date: 22 September 2010

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension

Amresh Shrivastava, Megan E Johnston, Nilesh Shah, et al

Neuropsychiatric Disease and Treatment 2010, 6:633-638

Published Date: 22 September 2010

Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions

Frederick Cassidy

Neuropsychiatric Disease and Treatment 2010, 6:627-631

Published Date: 21 September 2010

Assessing suicidal risk with antiepileptic drugs

Marco Mula, Gail S Bell, Josemir W Sander

Neuropsychiatric Disease and Treatment 2010, 6:613-618

Published Date: 14 September 2010

Effective ultrasonic virtual sources which can be positioned independently of physical aperture focus positions

Chikayoshi Sumi, Shinya Uga

Reports in Medical Imaging 2010, 3:45-59

Published Date: 10 September 2010

Brain amyloid β protein and memory disruption in Alzheimer’s disease

Weiming Xia

Neuropsychiatric Disease and Treatment 2010, 6:605-612

Published Date: 7 September 2010

Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite

Takahiro Ueno, Hironori Tsuchiya, Maki Mizogami, Ko Takakura

Journal of Inflammation Research 2008, 1:41-48

Published Date: 13 November 2008